Sintilimab,Cisplatin,Paclitaxel,5-fluorouracil
Innovent Biologics,eli lilly
['orient15', 'sintilimab', 'orien', 'esophageal', 'innovent']
#innovent releases final analysis results of #orient15 the phase 3 study of #sintilimab plus #chemotherapy for the first-line treatment of #esophagealsquamouscellcarcinoma at the #aacr23 
Follow top-line development in the oncology commercial domain through our award winning intelligence service, 1stOncology.